Delivery Order SPE2DB20D9329-SPE2DB23FZK34
Award Date 3/22/23
Potential Completion Date 4/12/23
Potential Value $41K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $6,291.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,556,217,484 units of the contraceptive implant NEXPLANON 68 MG and has a completion date of February 28, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,082.93, is for the delivery of 4,568,187,298 units of the contraceptive implant Nexplanon. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $12,864.42 to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,257,903 units of the contraceptive implant NEXPLANON 68 MG by May 1, 2024. This delivery order is part of a larger five-year indefinite delivery, indefinite quantity (IDIQ) contract, SPE2DB24D9238|SPE2DB24FDQDS, valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,024.40 contract is for the delivery of 4,562,125,118 units of Nexplanon 68 MG implants, a contraceptive product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31,...
- This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
- This is a $3,698.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for 4,558,244,879 units of Nexplanon 68 mg implants, a contraceptive product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which allows the DLA to issue firm...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $32,819.52 and covers the delivery of 4,562,313,640 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,943.10, is for the delivery of 4,567,991,932 units of the contraceptive implant Nexplanon 68 mg. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,839.36 firm fixed-price contract is for the delivery of 4,558,422,503 units of the contraceptive implant Nexplanon 68 mg. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 held by DMS Pharmaceutical Group with the DLA, which enables...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,984.32 contract was awarded by the Defense Logistics Agency (DLA) to provide 4,566,445,964 units of the contraceptive implant NEXPLANON 68 MG for a period ending on December 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB23FZK34Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,024.40 contract is for the delivery of 4,560,374,802 units of the contraceptive implant Nexplanon 68 mg. The delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract has no set-aside designation.
Generated 1/9/25, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.0k | 3/22/23 |